Will psilocybin remain Schedule I through the end of 2027?
Politique américaineOne-OffSanté et médecineÉchecsSportRégulation1aManifold MarketsSans KYCDonnées de résolution vérifiéesAssez bien calibréPrévision communautaire actuelleOui 92%
Prévisionnistes
3
Type de question
binary
Méthodologie
Play-money forecasting platform
Type de source
Prévision
Données du marché
Mis à jour il y a 7 minutes
9 juin 26, 18:18 UTC31 déc. 27, 23:59 UTC
Tendances
Marchés Associés
Questions liées pour le contexte, et non une comparaison de contrats équivalents.
Any province legalizes psilocybin for recreational use?
Manifold MarketsWill any psychedelic be rescheduled from Schedule I before January 1, 2028?
Manifold Markets[ACX 2026] Will the FDA approve a psilocybin treatment during 2026?
Manifold MarketsWill Psilocybin mushrooms be legal to own in Illinois by end of year 2050?
Manifold MarketsWill projects which recently received grants via FTX Foundation, Inc. (i.e., the non-profit entity associated with the Future Fund) receive a demand to give the money back (e.g., to be distributed among FTX bankruptcy creditors)?
Manifold MarketsWill Wisconsin Question 3 (ban on government preferential treatment) be approved in the November 3, 2026 election?
Manifold MarketsRègles
OOTWOracle's AI swarm (8 agents, daily deliberation since April 2026) holds this at 88% confidence.
- Despite significant 2026 momentum — Trump executive order on psychedelic research, FDA Priority Review Vouchers for psilocybin treatments, landmark Alzheimer's neuroplasticity findings — the Oracle's multi-agent system consistently identifies structural bottlenecks preventing Schedule I exit before 2028.
- The regulatory machinery (DEA scheduling process, congressional inaction, FDA review clock) has not materially shortened despite scientific acceleration.
- Full Oracle deliberation: ootworacle.com/oracle-chamber/2026-06-09
- Full prediction record: ootworacle.com/predictions
- NO = psilocybin exits Schedule I before Jan 1, 2028.
